Congress
Musk pitches weight-loss drugs to lower health care spending
Elon Musk, who is spearheading President-elect Donald Trump’s Department of Government Efficiency, is touting GLP-1 drugs to treat obesity.
“Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors [sic] super low cost to the public,” Musk wrote in a post on X Wednesday. “Nothing else is even close.”
Musk’s comments come just two weeks after the Biden administration made an 11th-hour push to require Medicare and state Medicaid programs to cover obesity drugs. The administration is proposing to reinterpret a 2003 law banning Medicare from covering popular GLP-1s directly for weight loss to do so.
The Biden administration’s proposal comes as the treatments can often be out of reach for consumers due to their cost, lack of insurance coverage and drug shortages. Congress is weighing legislation to lift the ban, which would dramatically expand access to the drugs but also would likely cost tens of billions of dollars.
Musk is leading the “DOGE” effort along with biotech entrepreneur Vivek Ramaswamy, and has pledged to cut trillions in federal spending. Congressional Republicans have said it’s too early to lay claim to top priorities or cost-cutting moves, but a DOGE framework has started to take shape.
It’s not clear how Musk would make GLP-1s “super low cost.” The drugs are expected to be eligible for Medicare price negotiation down the line, which could be one potential avenue to reduce their cost. The pharmaceutical industry and business interests have challenged in court the Inflation Reduction Act’s provisions establishing the price negotiations.
Still, Musk is pitching the drugs as a long-term cost saver.
“Vast majority of healthcare spending is near end of life and obesity often plays a major role,” Musk said in a July post on X. “GLP and other hunger inhibitors might be the single biggest positive effect on healthcare and quality of life in the 21st century.”
The Congressional Budget Office has said it doesn’t have direct evidence showing that using GLP-1s for obesity reduces other health care spending.
Musk could have an ally in Trump’s pick to run CMS, Dr. Mehmet Oz, who has touted Novo Nordisk’s Ozempic for weight loss. But Trump’s pick to run HHS, Robert F. Kennedy Jr., has been skeptical of the drugs.
Kennedy has raised concerns about cost and said in a recent Fox News interview that pharmaceutical companies are “counting on selling it to Americans because we’re so stupid and so addicted to drugs.”
House Democrats’ campaign arm is expanding its target list just three weeks ahead of Election Day, going on the air for the first time in four more districts with coordinated ad buys with the candidates.
The move, part of $13 million in coordinated ads launching this week across 39 districts and first shared with Blue Light News, is the Democratic Congressional Campaign Committee’s largest reach of investments this cycle as Republicans are working to defend a slew of redder seats in the final stretch.
The new districts include a toss-up race in Florida’s newly redrawn 22nd District, which Trump would have won by 10 points in 2024, as well as for Democrats’ uphill fight to defend Maine’s 2nd District, which President Donald Trump carried by nine points and where Democratic Rep. Jared Golden is retiring.
They’re also launching coordinated ads in New Jersey’s swingy 7th District, squarely within New York City’s expensive media market, where Democrats are working to unseat GOP Rep. Tom Kean Jr.
The coordinated ad buys also include Texas’s redrawn 35th District, where Democrat Johnny Garcia is running neck and neck with Republican Carlos De La Cruz in a suburban San Antonio district Republicans drew to win that Trump would have carried by 10 points.
The DCCC’s move comes as President Donald Trump’s MAGA Inc.-aligned super PAC and a leading House GOP super PAC are planning to ditch spending in a group of House races in the coming days, as they race to shore up other House seats and salvage the Senate GOP majority.
“As Republicans pull out of media markets and cede that they are no longer competitive in multiple districts, the DCCC is continuing to go on the offensive,” DCCC National Political Director Brooke Butler said.
The NRCC has been up with ads in the four districts for weeks.
“While Democrats are just now scraping together the cash to bail out their radical socialists in critical battleground districts, House Republicans have been dominating the airwaves in those same districts and dozens more for weeks,” NRCC spokesperson Mike Marinella said. “The DCCC is desperately playing catch-up where Republicans have already lapped them.”
The DCCC didn’t share the exact size of the specific coordinated ad buys, only saying they were six-figure commitments.
Former Rep. Mary Peltola raked in $17 million over the last three months, her campaign shared first with Blue Light News, a sizable haul for the Democratic challenger in one of the biggest Senate battlegrounds.
It’s Peltola’s largest quarterly fundraising total in her bid to oust GOP Sen. Dan Sullivan. Her campaign also said it’s a record third-quarter sum for a Senate candidate in Alaska.
“Alaskans are sick and tired of DC politicians making life more expensive for everyone while they keep lining their own pockets, and they know it’s time for a change,” Peltola said in a statement thanking her supporters.
That total includes nearly $3 million in Peltola raised in July, before Alaska’s all-party primary in August, which was previously reported to the Federal Election Commission. Peltola’s campaign did not release her cash on hand for the quarter that ended Oct. 1.
Sullivan’s campaign has not yet released his third-quarter numbers. Sullivan had just under $7.3 million in cash on hand as of July 29, while Peltola had $4.6 million at that point.
Alaska has emerged as a core battleground this cycle as both parties reorient around redder states while Georgia and North Carolina tilt toward Democrats. Recent polls show a tight race.
Republicans are racing to shore up Sullivan in the four-way, ranked-choice general election in which the senator is also facing a same-name challenger in retired teacher Dan J. Sullivan. Some in the party fear he could siphon votes from the incumbent.
President Donald Trump is heading to Alaska for a rally later Tuesday in Wasilla that Sullivan is slated to attend, the senator’s campaign confirmed. Vice President JD Vance swung through the state last week.
Peltola’s fundraising prowess has helped her hold her own on the airwaves. Republicans hold a slim spending advantage on the TV ad reservations for the final three weeks of the campaign, with both parties posting over $9 million in reservations, per tracker AdImpact.
Republicans’ dreams of a productive lame-duck session are dimming.
Members returning to Washington post-election will have a mere 24 legislative days to get through a considerable list of must-pass bills and possibly messy internal leadership fights. That’s if they can overcome a potential transition of power on Capitol Hill and a foul national mood.
Lawmakers’ must-do list includes: an extension of government funding past Dec. 11 and the annual Pentagon policy bill. Major legislation to reauthorize farm, transportation and surveillance programs are also on deck.
Then there are pending bipartisan bills overhauling energy permitting and the college sports industry that many members are itching to get done.
And finally, leaders had deferred some GOP priorities — such as another party-line reconciliation bill or debt-limit increase through the end of President Donald Trump’s term.
All of the measures face their own potential political minefields individually, as well as a number of obstacles across the board:
— ATTENDANCE: There will be little incentive for lawmakers who just lost their seats — “free-range chickens,” some call them — to grind out legislative wins, if they come back at all.
“The question becomes: Who shows up for work after the elections?” Rep. Austin Scott said in an interview. “Attendance is an issue right now.”
— NEW LEVERAGE: If Democrats win control of either chamber, they’ll likely seek greater influence on legislation to push back on Trump’s actions.
For example, Democrats are fuming over the Trump administration’s recent decision to block roughly $1 billion in congressionally approved funding, which could complicate any deal on spending legislation. They’ve also blocked the annual Pentagon policy bill amid a standoff over the Iran war; and they may push for more concessions on the permitting deal.
“The lame duck will be quite different if we win the Senate,” Minority Leader Chuck Schumer said in a recent interview.
— GOP DISPUTES: While some Republicans believe that losing a chamber would jump-start the reconciliation process, others privately believe the exact opposite would happen, with incentives waning for exiting lawmakers, according to three GOP aides granted anonymity to speak candidly.
Other GOP senators, like Sen. Cynthia Lummis, are skeptical of a debt-limit increase.
A Democratic flip of the House could also spark a potentially chaotic cascade of GOP leadership elections (more on that below).
Sen. John Kennedy speculated Congress’ agenda would all come down to the vibes of the GOP conference when they returned.
“You have no idea what the mood is going to be,” Kennedy said.
What else we’re watching:
— JOHNSON SCRAMBLES LEADERSHIP OUTLOOK: Republicans are reassessing the dynamics of potential leadership races after Speaker Mike Johnson‘s comments Monday that he would run for minority leader if the GOP loses the House — just days after he floated leaving Congress altogether in that scenario. Many Republicans had predicted Johnson would step aside with a House flip, likely setting off a race between Majority Leader Steve Scalise and Judiciary Chair Jim Jordan for the top GOP spot. If Johnson stays put, his success may depend on the severity of the party’s loss and if Trump weighs in for a certain candidate. “I hope he’s smarter than that,” one House Republican said of Johnson’s consideration of the minority leader role. “It would end very badly and cause unnecessary damage to the conference.”
— DEMS GEAR UP ON TRADE OVERSIGHT — Democrats on the House Ways and Means, Senate Finance and other panels say Trump’s trade deals were corrupt, and they’re already lining up targets to probe. The party knows it can’t repeal Trump’s tariffs as long as he’s in the White House, but if they win control of Congress, they plan to haul in top administration officials and possibly executives to explain how Trump picked his targets in his trade war — and if others got a pass through suspected quid pro quos.
Jordain Carney, Daniel Desrochers and Oliver Ward contributed to this report.
-
Politics2 years agoFormer ‘Squad’ members launching ‘Bowman and Bush’ YouTube show
-
Uncategorized2 years ago
Bob Good to step down as Freedom Caucus chair this week
-
The Josh Fourrier Show2 years agoDOOMSDAY: Trump won, now what?
-
The Dictatorship2 years agoPete Hegseth’s tenure at the Pentagon goes from bad to worse
-
Politics2 years agoFormer Kentucky AG Daniel Cameron launches Senate bid
-
The Dictatorship2 years agoLuigi Mangione acknowledges public support in first official statement since arrest
-
Politics2 years agoBlue Light News’s Editorial Director Ryan Hutchins speaks at Blue Light News’s 2025 Governors Summit
-
The Dictatorship1 year agoMike Johnson sums up the GOP’s arrogant position on military occupation with two words